Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Pain Management Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Drug Class
5.5 Market Breakup by Indication
5.6 Market Breakup by Distribution Channel
5.7 Market Breakup by Region
5.8 Market Forecast

6 Market Breakup by Drug Class
6.1 NSAIDs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Anesthetics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Anticonvulsants
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Antimigraine Agents
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Antidepressants
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Opioids
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast

7 Market Breakup by Indication
7.1 Musculoskeletal Pain
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Surgical and Trauma Pain
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cancer Pain
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Neuropathic Pain
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Migraine Pain
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Obstetrical Pain
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Fibromyalgia Pain
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Burn Pain
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Dental/Facial Pain
7.9.1 Market Trends
7.9.2 Market Forecast
7.10 Pediatric Pain
7.10.1 Market Trends
7.10.2 Market Forecast
7.11 Others
7.11.1 Market Trends
7.11.2 Market Forecast

8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Europe
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Asia Pacific
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories, Inc.
14.3.2 Pfizer, Inc.
14.3.3 Eli Lilly & Company
14.3.4 Endo International plc
14.3.5 F. Hoffmann-La Roche AG
14.3.6 Bausch Health Companies, Inc.
14.3.7 Merck & Co. Inc.
14.3.8 Allergen Inc.
14.3.9 Novartis International AG
14.3.10 Johnson & Johnson Private Limited
14.3.11 GlaxoSmithKline Plc
14.3.12 Purdue Pharma L.P